Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT06959524
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
Not applicable · Australia, China, Germany, Spain, Ireland, Japan, South Korea, New Zealand, United States · 71 sites
Registry update: 20 Oct 2026
NCT07082686
Recruiting
A Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (APEX-06)
Phase 2 · China · 29 sites
Registry update: 23 Jul 2026
NCT07058077
Recruiting
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
Phase 2/3 · Australia, Belgium, Brazil, Chile, China, Colombia, Czechia, Germany, Spain, Finland, France, United Kingdom, Italy, Japan, Mexico, Netherlands, Norway, New Zealand, Poland, Singapore, United States · 55 sites
Registry update: 10 Nov 2026
2024-519667-18-00
Recruiting
Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and teres ligament patch (PANENCA): an international randomized controlled multicenter trial
Phase 4 · Belgium, Denmark, Finland, Italy, Netherlands, Norway, Sweden · 24 sites
Registry update: 17 Sept 2026
NCT07899996
Recruiting
A Study of HB0056 in Adult Participants With Moderate to Severe Asthma
Phase 1/2 · China · 1 site
Registry update: 28 Oct 2026
NCT07013903
Recruiting
Effects of Hydrotherapy During Post-COVID-19 Rehabilitation
Not applicable · Germany · 1 site
Registry update: 28 Aug 2025
NCT06958107
Recruiting
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy and Spectroscopy-based Molecular Urinalysis in Sarcoma Patients
Not applicable · United States · 2 sites
Registry update: 21 Oct 2026
NCT07154706
Recruiting
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Phase 3 · Belgium, Canada, China, Germany, Spain, France, Italy, United States · 59 sites
Registry update: 19 May 2026
NCT06960096
Recruiting
Cognitive Decline Following Deep Brain Stimulation: A DBS-fMRI Study
Not applicable · United States · 1 site
Registry update: 8 Oct 2026
NCT07055399
Recruiting
Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC)
Phase 2 · China · 1 site
Registry update: 11 Sept 2025
NCT06993675
Recruiting
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
Phase 2 · United States · 3 sites
Registry update: 6 Nov 2026
NCT07090499
Recruiting
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1 · Canada, China, Spain, United Kingdom, Puerto Rico, United States · 30 sites
Registry update: 5 Nov 2026
NCT07150663
Recruiting
Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
Phase 3 · China · 1 site
Registry update: 8 Sept 2025
NCT07042152
Recruiting
Wearable Device and Behavioral Support for Enhancing Arm Use After Stroke
Not applicable · United States · 1 site
Registry update: 19 Aug 2025
NCT07111832
Recruiting
A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
Phase 3 · China · 2 sites
Registry update: 18 Dec 2025
NCT06984562
Recruiting
Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
Not applicable · United States · 1 site
Registry update: 29 Oct 2026
NCT07070128
Recruiting
Screening Tool Artificial Intelligence-based for Predicting the Genetic Risk of BREAST Cancer
Not applicable · Brazil · 2 sites
Registry update: 29 Jul 2026
NCT07143110
Recruiting
LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
Not applicable · Canada · 2 sites
Registry update: 3 Sept 2026
NCT07183878
Recruiting
Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)
Not applicable · China · 1 site
Registry update: 2 Sept 2026
NCT07230652
Recruiting
A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
Phase 1 · China · 1 site
Registry update: 19 Nov 2025

Ordered by registry start date. Freshness and sponsorship never change the order.